-$37.6 (-2.64%)
Industry, Sector & symbol
Stock Exchange | Bombay Stock Exchange |
CEO | Dr. Habil Fakhruddin Khorakiwala |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Current Symbol | WOCKPHARMA.BO |
CUSIP | None |
CIK | None |
Web | https://www.wockhardt.com |
Phone | 91 24 0669 4444 |
Currency | INR |
Employees | 2386 |
Country | IN |
Liquidity
Debt-to-Equity Ratio | 0.63 |
Payout Ratio | 0.00 |
Current Ratio | 0.84 |
Quick Ratio | 0.57 |
Cash Ratio | 0.06 |
Sales & Book Value
Annual Sales | $27.89B |
Price / Sales | 7.71 |
Cash Flow | 14.70 |
Price / Cash Flow | 103.37 |
Price / Book | 6.17 |
Price Target and Rating
Average Stock Price Forecast | $ |
High Stock Price Forecast | $ |
Low Stock Price Forecast | $ |
Forecast Upside/Downside | % |
Consensus Rating | Strong Sell |
Rating Score(0-5) | 1 |
Research Coverage | 0 Analysts |
Profitability
EPS (Most Recent Fiscal Year) | $-32.1 |
Trailing P/E Ratio | -72.74 |
PEG Ratio | -4.46 |
P/E Growth | -4.46 |
Net Income | $-4.63B |
Net Margin | -9.77% |
Pretax Margin | -9.56% |
Return on Equity | -8.32% |
Return on Assets | -3.80% |
Financials Score
AltmanZ Score | 3.92 |
Piotroski Score | 3.00 |
Working Capital | -3.72B |
Total Assets | 75.88B |
Ebit | 140M |
Market Cap | 231.62B |
Total Liabilities | 38.75B |
About Wockhardt Limited (BSE:WOCKPHARMA.BO) Stock
Wockhardt Limited, a pharmaceutical and biotech company, manufactures and markets pharmaceuticals, medicinal, and chemical products in India, the United States, the United Kingdom, Switzerland, Ireland, Mexico, Russia, and internationally. It develops various molecules primarily in the areas of infectious diseases, such as WCK 5222, WCK 4282, WCK 4873, WCK 771 and WCK 2349, and WCK 6777 molecules; and active pharmaceutical ingredients. The company's biopharmaceutical products include Glaritus, a long-acting biosimilar glargine; Wosulin, a recombinant human insulin; Wepox, an r-DNA erythropoietin; human insulin; and Biovac-B, a hepatitis B vaccine. Its pipeline also includes long-acting insulin analogues, concentrated insulins, GLP1 analogues, haemopoietins, biobetters and novel products, a ... nd delivery devices. It also provides contract manufacturing services. The company was founded in 1967 and is headquartered in Mumbai, India.
Frequently Asked Questions
What is the current Wockhardt Limited (WOCKPHARMA.BO) stock price?
Wockhardt Limited(BSE:WOCKPHARMA.BO) stock price is $1388.05 in the last trading session. During the trading session, WOCKPHARMA.BO stock reached the peak price of $1467.0 while $376.5 was the lowest point it dropped to. The percentage change in WOCKPHARMA.BO stock occurred in the recent session was --2.64% while the dollar amount for the price change in WOCKPHARMA.BO stock was -$-37.6.
WOCKPHARMA.BO's industry and sector of operation?
The BSE listed WOCKPHARMA.BO is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
Who are the executives of WOCKPHARMA.BO?
Mr. Zoher T. Sihorwala
| Head of Global Regulatory Affairs
Mr. Deepak R. Madnani
| Chief Financial Officer
Mr. Prakash Gupta
| President of Supply Chain
Ms. Debolina Partap
| Senior Vice President of Legal
Dr. Habil Fakhruddin Khorakiwala
| Founder & Executive Chairman
How many employees does WOCKPHARMA.BO have?
Number of WOCKPHARMA.BO employees currently stands at 2386. WOCKPHARMA.BO operates from Wockhardt Towers, Mumbai, None 400051, IN.
Link for WOCKPHARMA.BO official website?
Official Website of WOCKPHARMA.BO is: https://www.wockhardt.com
How do I contact WOCKPHARMA.BO?
WOCKPHARMA.BO could be contacted at phone #91 24 0669 4444 and can also be accessed through its website. WOCKPHARMA.BO operates from Wockhardt Towers, Mumbai, None 400051, IN.
How many shares of WOCKPHARMA.BO are traded daily?
The average number of WOCKPHARMA.BO shares traded daily for last 3 months was 50.86K.
What is the market cap of WOCKPHARMA.BO currently?
The market value of WOCKPHARMA.BO currently stands at $225.51B with its latest stock price at $1388.05